Stock AREC ARECOR THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Delayed London S.E.
Other stock markets
 02:59:59 2024-05-22 am EDT 		5-day change 1st Jan Change
158.5 GBX 0.00% Intraday chart for Arecor Therapeutics plc +16.12% -13.15%
May. 20 Arecor Therapeutics' Investigational Insulin Shows Fast Absorption in Early-stage Study MT
May. 20 Arecor Therapeutics hails positive profile for insulin AT278 AN

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Arecor Therapeutics plc - Special Call
At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
AQ
Arecor Therapeutics' Investigational Insulin Shows Fast Absorption in Early-stage Study
MT
Arecor Therapeutics hails positive profile for insulin AT278
AN
Arecor Therapeutics reports strong 2023 results and outlines expanding product pipeline
AQ
EARNINGS AND TRADING: Michelmersh continues with positive order intake
AN
Transcript : Arecor Therapeutics plc, 2023 Earnings Call, May 16, 2024
Earnings Flash (AREC.L) ARECOR THERAPEUTICS Posts FY23 Revenue GBP4.6M
MT
Earnings Flash (AREC.L) ARECOR THERAPEUTICS Reports FY23 Loss GBP-0.28
MT
Arecor Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Arecor Therapeutics collaborates with Medtronic on novel insulin
AN
Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development
MT
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
AQ
Arecor and Medtronic Diabetes Collaboration
CI
Arecor Therapeutics delays publication of 2023 results
AN
Arecor Therapeutics plc Announces Delay in Publication of the Group's Final Results for the Year Ended 31 December 2023
CI
Arecor chief financial officer to leave in July after five years
AN
Arecor Therapeutics CFO to Leave in July
MT
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Chief Financial Officer, Effective from July 22, 2024
CI
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Company Secretary and as A Board Director, Effective from July 22,2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AREC Stock
  4. News Arecor Therapeutics plc
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW